Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIND.L Regulatory News (IND)

  • There is currently no data for IND

Trading update and Board changes

24 Nov 2017 07:00

RNS Number : 4136X
IndigoVision Group PLC
24 November 2017
 

 

 

 

 

IndigoVision Group plc ("IndigoVision", the "Group")

 

Trading update and Board changes

 

There are several important trading weeks before the end of the Group's financial year on 31 December, but it is now clear that management's expectations will not be achieved and that a full year operating loss will be reported. The management and sales team changes in the US are showing continued signs of delivery, with further growth in the sales pipeline, but the Middle East has experienced more difficult trading conditions, with unforeseen delays in securing a number of large contracts.

Current expectations are that revenue for the year will be in the region of $41m to $43m. Gross margins for the year are likely to be a little ahead of those achieved last year and total overheads are expected to be around 5% higher than last year, due principally to the investment in the US described within the Interim Results statement. The financial position of the Group remains strong, with current cash balances of $2.5m and bank facilities of $4.0m which remain undrawn.

 Marcus Kneen has resigned from the Board and has ceased to be Chief Executive Officer with immediate effect. The Board would like to thank Marcus for his contribution to IndigoVision over the last 14 years.

 

Pedro Simoes, who was appointed as Senior Vice President - Global Sales on 2 October 2017, has been appointed as Interim Chief Executive Officer and will join the Board as an executive director as soon as practicable, subject to the completion, by N+1 Singer, of the necessary regulatory due diligence. A further announcement confirming Pedro Simoes' appointment to the Board, including the necessary regulatory disclosures, will be made as and when appropriate.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

For further information please contact:

 

IndigoVision Group plc

George Elliott, Chairman

Chris Lea, CFO +44 131 475 7200

 

N+1 Singer, Nominated Adviser

Sandy Fraser +44 207 496 3000

 

Media Enquiries:

Charlotte Street Partners

Malcolm Robertson +44 7788 567680

 

 

About Indigovision

 

IndigoVision is a leader in the design and supply of high performance, highly-intelligent video security systems for security installations of differing sizes and complexity. From video capture and transmission to analysis and storage, IndigoVision's networked video security systems provide the best quality and most secure video evidence, using market leading compression technology to minimise bandwidth and reduce storage costs.

 

IndigoVision's technology is ideally suited for use in mission critical facilities such as government, oil and gas, transport, cities, industry, education, police, prisons and casinos to improve public safety, protect assets, develop organisations' operational efficiency and support law enforcement.

 

IndigoVision has sales and support teams in 23 countries and operates through 18 regional centres, in Edinburgh, London, Paris, Amsterdam, Dusseldorf, Johannesburg, Dubai, Mumbai, Singapore, Macau, Shanghai, Sydney, Mexico City, Toronto, Bogotá, New Jersey, Buenos Aires and Sao Paulo.

IndigoVision partners with a network of some 1,000 trained and authorised IndigoVision resellers to provide local system design, installation and servicing to IndigoVision's system users.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBJBJTMBTTTMR
Date   Source Headline
25th Jun 20152:17 pmRNSBlocklisting Interim Review
9th Jun 201511:46 amRNSDirector/PDMR Shareholding
6th May 20152:49 pmRNSResult of AGM
30th Apr 201510:02 amRNSHolding(s) in Company
29th Apr 201512:01 pmRNSHolding(s) in Company
28th Apr 201511:59 amRNSTrading Statement
1st Apr 20154:00 pmRNSBlocklisting Interim Review
1st Apr 201511:38 amRNSHolding(s) in Company
18th Mar 20159:16 amRNSHolding(s) in Company
2nd Mar 20159:33 amRNSHolding(s) in Company
26th Feb 20157:01 amRNSFinal Results
8th Jan 20155:48 pmRNSHolding(s) in Company
8th Jan 20153:31 pmRNSHistoric Financial Information in US Dollars
7th Jan 20154:02 pmRNSHolding(s) in Company
6th Jan 20157:00 amRNSTrading Update
5th Jan 20159:57 amRNSHolding(s) in Company
9th Dec 20148:55 amRNSHolding(s) in Company
3rd Dec 20141:21 pmRNSHolding(s) in Company
14th Nov 201410:40 amRNSHolding(s) in Company
11th Nov 20147:00 amRNSTrading Update
20th Oct 201411:53 amRNSHolding(s) in Company
30th Sep 20143:33 pmRNSExercise of Options
17th Sep 20141:17 pmRNSBlocklisting Interim Review
17th Sep 20147:00 amRNSInterim Results
6th Aug 20147:00 amRNSTrading Update
29th Jul 20147:00 amRNSHolding(s) in Company
28th Jul 20142:06 pmRNSHolding(s) in Company
7th Jul 20145:25 pmRNSDirector participation in Partnership Share Award
10th Jun 20147:00 amRNSDirector/PDMR Shareholding
29th May 20147:00 amRNSHolding(s) in Company
8th May 201412:35 pmRNSDirector/PDMR Shareholding
8th May 201412:34 pmRNSDirector/PDMR Shareholding
8th May 20149:30 amRNSDirector/PDMR Shareholding
10th Apr 201412:02 pmRNSDirector/PDMR Shareholding
6th Mar 20143:15 pmRNSDirector/PDMR Shareholding
6th Mar 20147:00 amRNSFirst Interim Results
17th Feb 20144:28 pmRNSHolding(s) in Company
29th Jan 20149:57 amRNSTotal Voting Rights and Posting of Annual Report
15th Jan 20141:43 pmRNSHolding(s) in Company
9th Jan 20149:07 amRNSExercise of Options
7th Jan 201410:10 amRNSHolding(s) in Company
2nd Jan 201412:06 pmRNSDirectorate Change
27th Dec 20139:06 amRNSBlocklisting Interim Review
5th Dec 20135:24 pmRNSHolding(s) in Company
4th Dec 20133:01 pmRNSHolding(s) in Company
12th Nov 20133:37 pmRNSResult of AGM
12th Nov 201311:00 amRNSAGM Statement
5th Nov 20133:21 pmRNSHolding(s) in Company
29th Oct 20132:07 pmRNSHolding(s) in Company
10th Oct 20139:38 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.